SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-006468
Filing Date
2023-02-28
Accepted
2023-02-28 18:56:45
Documents
1
Period of Report
2023-02-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4010
  Complete submission text file 0000899243-23-006468.txt   5368
Mailing Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355
Business Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Issuer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GALERA THERAPEUTICS, INC. 2 W LIBERTY BOULEVARD, #110 MALVERN PA 19355
Business Address
Bachleda Mark (Reporting) CIK: 0001887762 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39114 | Film No.: 23688600